Hill-Rom Holdings Inc. (NYSE:HRC)’s share price rose 3.3% during mid-day trading on Wednesday . The company traded as high as $52.37 and last traded at $52.23, with a volume of 432,140 shares. The stock had previously closed at $50.55.

HRC has been the subject of a number of research reports. Goldman Sachs Group Inc. increased their target price on Hill-Rom Holdings from $52.00 to $55.00 in a report on Friday, April 8th. Morgan Stanley upgraded Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $54.00 to $62.00 in a report on Thursday, June 16th. KeyCorp reiterated a “buy” rating and set a $59.00 target price on shares of Hill-Rom Holdings in a report on Thursday, June 23rd. Zacks Investment Research cut Hill-Rom Holdings from a “strong-buy” rating to a “hold” rating in a report on Monday, April 4th. Finally, Bank of America Corp. reiterated a “buy” rating and set a $69.00 target price on shares of Hill-Rom Holdings in a report on Monday, May 2nd. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Hill-Rom Holdings currently has an average rating of “Buy” and an average target price of $59.83.

The company has a 50-day moving average price of $50.34 and a 200-day moving average price of $49.00. The firm has a market capitalization of $3.40 billion and a P/E ratio of 88.29.

Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings results on Friday, April 29th. The medical technology company reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.01. During the same quarter in the previous year, the company posted $0.64 earnings per share. The business had revenue of $633 million for the quarter, compared to analysts’ expectations of $650.99 million. The business’s quarterly revenue was up 33.2% compared to the same quarter last year. Analysts anticipate that Hill-Rom Holdings Inc. will post $3.27 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, June 24th. Investors of record on Friday, June 10th were paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date of this dividend was Wednesday, June 8th.

Other hedge funds have made changes to their positions in the company. GSA Capital Partners LLP boosted its stake in shares of Hill-Rom Holdings by 6.1% in the fourth quarter. GSA Capital Partners LLP now owns 24,630 shares of the medical technology company’s stock worth $1,184,000 after buying an additional 1,423 shares during the last quarter. Engineers Gate Manager LP acquired a new stake in shares of Hill-Rom Holdings during the fourth quarter worth approximately $1,451,000. Trexquant Investment LP acquired a new stake in shares of Hill-Rom Holdings during the fourth quarter worth approximately $1,662,000. Marshall Wace LLP acquired a new stake in shares of Hill-Rom Holdings during the fourth quarter worth approximately $1,674,000. Finally, Liberty Mutual Group Asset Management Inc. boosted its stake in shares of Hill-Rom Holdings by 51.4% in the fourth quarter. Liberty Mutual Group Asset Management Inc. now owns 36,355 shares of the medical technology company’s stock worth $1,747,000 after buying an additional 12,339 shares during the last quarter.

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.